Sang-Woo Lee
Director/Miembro de la Junta en Geneos Therapeutics, Inc. .
Perfil
Sang-Woo Lee currently works at Korea Investment Partners Co., Ltd., as Managing Director and Geneos Therapeutics, Inc., as Director from 2021.
Cargos activos de Sang-Woo Lee
Empresas | Cargo | Inicio |
---|---|---|
Korea Investment Partners Co., Ltd.
Korea Investment Partners Co., Ltd. Investment ManagersFinance Korea Investment Partners Co., Ltd(Korea Investment Partners). is a Private Equity/Venture Capital firm, a subsidiary of Korea Investment Holdings Co., Ltd. founded in 1986. Korea Investment Partners Co., Ltd. is headquartered in Seoul. | Inversor de Capital Privado | 14/04/2014 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Director/Miembro de la Junta | 03/03/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Korea Investment Partners Co., Ltd.
Korea Investment Partners Co., Ltd. Investment ManagersFinance Korea Investment Partners Co., Ltd(Korea Investment Partners). is a Private Equity/Venture Capital firm, a subsidiary of Korea Investment Holdings Co., Ltd. founded in 1986. Korea Investment Partners Co., Ltd. is headquartered in Seoul. | Finance |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Sang-Woo Lee